Form 4: Veracyte CFO Rebecca Chambers Reports Tax Withholding of Shares
SEC Form 4 Filing
Rebecca Chambers, CFO of Veracyte, reports the withholding of shares to cover tax obligations related to the vesting of restricted stock units.
Summary
- On June 2, 2024, Rebecca Chambers, the Chief Financial Officer of Veracyte, Inc., had shares of common stock withheld to satisfy tax obligations.
- A total of 3,462 shares were withheld at a price of $20.75 per share.
- This withholding was related to the vesting of restricted stock units granted on July 19, 2021, March 3, 2022, August 5, 2022, and March 6, 2023.
- The withheld shares do not represent a sale by Ms. Chambers.
- Following the transaction, Ms. Chambers beneficially owns 143,240 shares of Veracyte common stock.
Sentiment
Score: 5
Explanation: This is a neutral event related to standard executive compensation practices; it doesn't indicate positive or negative sentiment.
Industry Context
This is a routine filing related to executive compensation and tax obligations, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| July 19, 2021 | Date of grant for some of the restricted stock units. |
| March 3, 2022 | Date of grant for some of the restricted stock units. |
| August 5, 2022 | Date of grant for some of the restricted stock units. |
| March 6, 2023 | Date of grant for some of the restricted stock units. |
| June 02, 2024 | Date of transaction (tax withholding). |
| June 04, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.